Connect Biopharma Holdings Limited (CNTB)

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $45.39 million. The enterprise value is -$48.14 million.

Market Cap	45.39M
Enterprise Value	-48.14M

Important Dates

The last earnings date was Monday, March 31, 2025, before market open.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

CNTB has 55.35 million shares outstanding. The number of shares has increased by 0.27% in one year.

Current Share Class	n/a
Shares Outstanding	55.35M
Shares Change (YoY)	+0.27%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	22.62%
Owned by Institutions (%)	11.68%
Float	14.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.72
Forward PS	n/a
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.46, with a Debt / Equity ratio of 0.00.

Current Ratio	11.46
Quick Ratio	11.20
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -16.14% and return on invested capital (ROIC) is -14.44%.

Return on Equity (ROE)	-16.14%
Return on Assets (ROA)	-12.27%
Return on Invested Capital (ROIC)	-14.44%
Return on Capital Employed (ROCE)	-24.19%
Revenue Per Employee	$419,887
Profits Per Employee	-$252,065
Employee Count	62
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

In the past 12 months, CNTB has paid $223,000 in taxes.

Income Tax	223,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.80% in the last 52 weeks. The beta is -0.22, so CNTB's price volatility has been lower than the market average.

Beta (5Y)	-0.22
52-Week Price Change	-38.80%
50-Day Moving Average	0.77
200-Day Moving Average	1.05
Relative Strength Index (RSI)	56.90
Average Volume (20 Days)	269,924

Short Selling Information

Short Interest	64,978
Short Previous Month	5,404
Short % of Shares Out	0.19%
Short % of Float	n/a
Short Ratio (days to cover)	0.29

Income Statement

In the last 12 months, CNTB had revenue of $26.03 million and -$15.63 million in losses. Loss per share was -$0.28.

Revenue	26.03M
Gross Profit	26.03M
Operating Income	-22.45M
Pretax Income	-59.38M
Net Income	-15.63M
EBITDA	-21.79M
EBIT	-22.45M
Loss Per Share	-$0.28

Balance Sheet

The company has $93.71 million in cash and $178,000 in debt, giving a net cash position of $93.53 million or $1.69 per share.

Cash & Cash Equivalents	93.71M
Total Debt	178,000
Net Cash	93.53M
Net Cash Per Share	$1.69
Equity (Book Value)	92.17M
Book Value Per Share	1.67
Working Capital	88.50M

Cash Flow

In the last 12 months, operating cash flow was -$23.61 million and capital expenditures -$750,000, giving a free cash flow of -$24.36 million.

Operating Cash Flow	-23.61M
Capital Expenditures	-750,000
Free Cash Flow	-24.36M
FCF Per Share	-$0.44

Margins

Gross margin is 100.00%, with operating and profit margins of -86.24% and -60.03%.

Gross Margin	100.00%
Operating Margin	-86.24%
Pretax Margin	-59.17%
Profit Margin	-60.03%
EBITDA Margin	-83.71%
EBIT Margin	-86.24%
FCF Margin	n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.27%
Shareholder Yield	-0.27%
Earnings Yield	-34.43%
FCF Yield	-53.67%

Analyst Forecast

The average price target for CNTB is $8.00, which is 875.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	875.49%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	19.86%
EPS Growth Forecast (5Y)	-2.86%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CNTB has an Altman Z-Score of 0.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.54
Piotroski F-Score	1